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Aversive visceral stimuli, such as those associated with sickness, suppress appetite. Yet an understanding of
the neural mechanisms underlying illness-related anorexia has remained elusive. Carter et al. (2013) now
identify a specific hindbrain/ amygdala circuit that contributes to illness-induced loss of appetite.Hunger is a motivational state operation-
ally defined as the tendency to seek out,
work for, and eat food. Many stimuli
converge to affect hunger, including
homeostatic deficiency-related cues
(fasting increases hunger), the rewarding
aspects of food (dessert is readily eaten
after an otherwise energetically sufficient
meal), circadian rhythms (eating occurs
at certain times of day), learned environ-
mental cues associated with foods or
aversive experiences (we eat more during
the holidays and less when fearful), and,
finally, internal stimuli associated with
illness or visceral distress (Figure 1).
Indeed, while the question of why we do
eat is of immediate salience to the mod-
ern-day obesity crisis, the latter point
speaks to the potentially more vital ques-
tion of why, under certain conditions,
do we not eat? Carter et al. (2013) now
provide a neurological basis for the path-
ophysiological ‘‘loss of appetite’’ through
their identification of ‘‘illness-activated’’
calcitonin gene-related peptide (CGRP)-
expressing neurons in the lateral parabra-
chial nucleus (LPBN).
Hunger-promoting GABAergic AgRP
neurons are indispensible for feeding.
Located in the arcuate nucleus, they
are activated by fasting and are linked
to various aspects of energy homeosta-
sis (Cansell et al., 2012). Their targeted
ablation in mice (AgRPDTR) leads to com-
plete aphagia (Luquet et al., 2005) and
induces chronic neuronal activation and
excitotoxicity in downstream neuroana-
tomical targets, including the LPBN
(Wu et al., 2008). Importantly, starvation
in these animals was rescued by LPBN
administration of a GABA-receptor
agonist (Wu et al., 2009). Thus, inducible
ablation of AgRP neurons serves as a
unique model of anorexia that has
consistently pointed Palmiter’s grouptoward the LPBN as a site of functional
outflow.
As a somatosensory relay for peripher-
ally derived information, the LPBN inte-
grates sensory input from spinal afferents
(via the dorsal horn) and vagal afferents
(via the nucleus of the solitary tract) and
is reactive to a number of (patho)physio-
logic visceroceptive modalities. Discreet
subsets of LPBN neurons are activated
by specific visceral stressors, including
lipopolysaccharide (LPS; infection),
lithium chloride (LiCl; toxicity), and noci-
ceptive stimuli (pain), all known to sup-
press food intake. Building upon their pre-
vious work, Carter et al. (2013) now show
that LPBN CGRP-expressing neurons
contribute to aphagia in AgRPDTR mice,
and suppress appetite in response to
illness. Indeed, these cells were stimu-
lated by AgRP neuron ablation and
visceral stressors (LPS and LiCl). Func-
tionally, LPBN CGRP cells are sufficient
to suppress food consumption when arti-
ficially activated at times when animals
would normally be motivated to feed
(nocturnal and post-fast refeeding).
Furthermore, optogenetic terminal field
stimulation of CGRP projections within
the central nucleus of the amygdala, the
laterocapsular division (CeLC), recapitu-
lated feeding suppression, identifying
these projections as those underlying
CGRP neuron-induced anorexia. To pro-
vide physiological relevance, Carter et al.
(2013) tested the necessity of LPBN
CGRP neurons to suppress feeding within
basal and aversive contexts. CGRP
neuron silencing failed to promote a recip-
rocal increase in food consumption under
basal conditions. However, within the
context of visceral distress, inhibition of
these cells partially ameliorated LPS and
LiCl-induced anorexia, suggesting that
LPBN CGRP neurons are part of theCell Metabolism 18,neurocircuitry through which illness sup-
presses feeding. Finally, and consistent
with their earlier work, the authors reveal
that silencing of CGRP neurons com-
pletely rescues the lethal aphagia pheno-
type of AgRPDTR mice.
Illness-associated anorexia is caused
by an averse stimulus that reduces the
drive to eat. In contrast, anorexia arising
from satiety can be viewed as relief from
deficiency-related hunger. Traditionally,
AgRP neurons are associated with the
homeostatic control of hunger, activated
by states of energetic depletion and
suppressed by energetic repletion. Con-
sistently, their artificial activation in the
nutritionally replete state or their inhibition
in the deficient state stimulates and
inhibits feeding, respectively (Krashes
et al., 2011; Aponte et al., 2011). Further-
more, this functional reciprocity holds
true for the downstream paraventricular
hypothalamic neurons through which
AgRP neurons regulate homeostasis-
directed feeding (Atasoy et al., 2012)
(A.S.G. and B.B.L., unpublished data).
This tenet of deficiency-related hunger is
not upheld by LPBNCGRP neurons; while
their activation induces anorexia, their
inhibition does not promote intake in a
replete state, suggesting that CGRP neu-
rons influence context-specific (illness-
associated) anorexia but not homeostatic
control of appetite.
This functional dichotomy raises an
interesting question: How is a population
of deficiency-related hunger neurons
(AgRP) functionally integrated into a
somatosensory network associated with
illness-induced anorexia (CGRP)? This
issue is best addressed by considering
the two components of the system in
isolation. In the first instance, the capacity
of CGRP neurons to suppress feed-
ing under genuine pathophysiologicalDecember 3, 2013 ª2013 Elsevier Inc. 769
Figure 1. Neuroanatomical Integration of Behavioral and Physiological Cues Influencing
Hunger
The drive to eat is underscored by the concerted action of numerous neuroanatomical microcircuits
reactive to both internal (physiologic and pathophysiologic) signals and external environmental cues.
Abbreviations: AP, area postrema; ARC, arcuate nucleus of the hypothalamus; BLA, basolateral amyg-
dala; BNST, bed nucleus of the stria terminalis; DMH, dorsomedial nucleus of the hypothalamus; LHA,
lateral hypothalamic area; LPBN, lateral parabrachial nucleus; mPFC, medial prefrontal cortex; PVH,
paraventrical nucleus of the hypothalamus; NaC, nucleus accumbens; NTS, nucleus of the solitary tract;
SCN, suprachiasmatic nucleus; VTA, ventral tegmental area.
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the first to delineate a neurological frame-
work for illness-associated appetite loss.
Second, and divorced from this observa-
tion, is the involvement of AgRP neurons
and their physiological relevance to
CGRP neuron-induced anorexia. It is
possible, if not likely, that AgRP neuron
function transcends (patho)physiological
context, such that via specific and distinct
projections they promote feeding under
various circumstances. Thus, during
illness, when food consumption seems
aversive, LPBN-projecting AgRP neurons
temper CGRP neuron-induced anorexia
to ensure long-term viability of the organ-
ism. However, this presumes a functional
connection between hunger-promoting
AgRP neurons and anorexia-promoting
CGRP neurons. Through the identifica-
tion of cFOS induction, as a marker of770 Cell Metabolism 18, December 3, 2013 ªneuronal activation, in LPBN CGRP neu-
rons of AgRPDTR mice, Carter et al.
(2013) provide indirect evidence of this
connection. Yet, given that these mice
exhibit LPBN excitotoxicity, gliosis, and
inflammation, is it possible that AgRP
neuron ablation somehow promotes
chronic activation of resident CGRP
neurons (and subsequent anorexia),
secondary to withdrawal of AgRP
neuron-derived inhibition? Undoubtedly,
this model was invaluable in leading
Carter et al. (2013) to discover CGRP
neuron function, but within the context
of a neurologically intact animal the
physiological role of AgRP neurons in
their regulation remains unclear. To this
end, some questions remain. Are AgRP
neurons in synaptic contact with LPBN
CGRP neurons?Would synaptic silencing
of LPBNAgRP terminals (without ablation)2013 Elsevier Inc.promote anorexia via disinhibition of
CGRP neurons, or their activation under
visceral distress inhibit CGRP neurons
and ameliorate illness-induced anorexia?
Finally, is CGRP neuron activation aver-
sive in its own right? Although the authors
noted no overt signs of distress, given the
context under which they are activated,
it would be interesting to know if CGRP
neuron stimulation elicits conditioned
place aversion and/or taste aversion.
The data provided by Carter et al.
(2013) allude to the neuroanatomical
integration of hypothalamic AgRP neu-
rons into the somatosensory parabra-
chio-amygdalaoid axis. If substantiated
by further studies it would afford new
insight into how interoceptive awareness
of visceral state and the homeostatic
need for food are reconciled. Inde-
pendently, the involvement of CGRP
neurons in illness-induced anorexia is
of immediate clinical relevance. Infec-
tious and inflammatory conditions, even
those not impacting upon digestive
function, are associated with suppressed
appetite. The cellular components of
this LPBN / CeLC microcircuit may
yield novel therapeutic targets for the
re-establishment of appetite, potentially
aiding recuperation.REFERENCES
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